China’s Simcere Jumps After 2011 Profit Beats Estimates

Simcere Pharmaceutical Group, a Chinese drugmaker, jumped the most since 2008 after reporting that 2011 profit rose, beating analysts’ forecasts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.